Joanne Wuensch
Stock Analyst at Citigroup
(4.25)
# 384
Out of 5,163 analysts
465
Total ratings
62.5%
Success rate
10.14%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $250 → $274 | $241.52 | +13.45% | 18 | Mar 11, 2026 | |
| IRTC iRhythm Holdings | Maintains: Buy | $242 → $214 | $113.00 | +89.38% | 23 | Mar 11, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Sell | $11 → $9 | $9.24 | -2.60% | 17 | Mar 11, 2026 | |
| PODD Insulet | Maintains: Buy | $345 → $338 | $219.84 | +53.75% | 18 | Mar 11, 2026 | |
| HAE Haemonetics | Maintains: Neutral | $75 → $70 | $59.92 | +16.82% | 12 | Mar 11, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $88 → $84 | $70.77 | +18.69% | 9 | Mar 11, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $81 → $74 | $63.35 | +16.81% | 9 | Mar 11, 2026 | |
| DXCM DexCom | Maintains: Buy | $77 → $84 | $64.24 | +30.76% | 18 | Mar 11, 2026 | |
| BSX Boston Scientific | Maintains: Buy | $102 → $94 | $69.13 | +35.98% | 37 | Mar 11, 2026 | |
| BAX Baxter International | Maintains: Neutral | $21 → $19 | $17.40 | +9.20% | 23 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $136 | $108.03 | +25.89% | 24 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $590 | $472.16 | +24.96% | 20 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9.1 → $6.5 | $3.67 | +77.11% | 15 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $88 → $87 | $69.92 | +24.43% | 23 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $92 | $82.98 | +10.87% | 10 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $16.20 | +29.63% | 7 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $98 | $93.20 | +5.15% | 24 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $350 → $374 | $336.18 | +11.25% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $455 → $420 | $336.77 | +24.71% | 15 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $113 → $125 | $97.02 | +28.84% | 23 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $81.81 | +23.46% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $21.59 | +1.90% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $87.14 | +28.53% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.68 | +147.02% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $159.36 | +56.88% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $77.32 | -10.76% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $230.84 | -44.98% | 6 | Dec 10, 2018 |
Johnson & Johnson
Mar 11, 2026
Maintains: Buy
Price Target: $250 → $274
Current: $241.52
Upside: +13.45%
iRhythm Holdings
Mar 11, 2026
Maintains: Buy
Price Target: $242 → $214
Current: $113.00
Upside: +89.38%
Integra LifeSciences Holdings
Mar 11, 2026
Maintains: Sell
Price Target: $11 → $9
Current: $9.24
Upside: -2.60%
Insulet
Mar 11, 2026
Maintains: Buy
Price Target: $345 → $338
Current: $219.84
Upside: +53.75%
Haemonetics
Mar 11, 2026
Maintains: Neutral
Price Target: $75 → $70
Current: $59.92
Upside: +16.82%
GE HealthCare Technologies
Mar 11, 2026
Maintains: Neutral
Price Target: $88 → $84
Current: $70.77
Upside: +18.69%
Establishment Labs Holdings
Mar 11, 2026
Maintains: Neutral
Price Target: $81 → $74
Current: $63.35
Upside: +16.81%
DexCom
Mar 11, 2026
Maintains: Buy
Price Target: $77 → $84
Current: $64.24
Upside: +30.76%
Boston Scientific
Mar 11, 2026
Maintains: Buy
Price Target: $102 → $94
Current: $69.13
Upside: +35.98%
Baxter International
Mar 11, 2026
Maintains: Neutral
Price Target: $21 → $19
Current: $17.40
Upside: +9.20%
Mar 11, 2026
Maintains: Buy
Price Target: $140 → $136
Current: $108.03
Upside: +25.89%
Mar 11, 2026
Upgrades: Buy
Price Target: $590
Current: $472.16
Upside: +24.96%
Mar 6, 2026
Maintains: Neutral
Price Target: $9.1 → $6.5
Current: $3.67
Upside: +77.11%
Mar 6, 2026
Maintains: Neutral
Price Target: $88 → $87
Current: $69.92
Upside: +24.43%
Feb 20, 2026
Maintains: Neutral
Price Target: $75 → $92
Current: $82.98
Upside: +10.87%
Feb 19, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $16.20
Upside: +29.63%
Feb 11, 2026
Maintains: Neutral
Price Target: $94 → $98
Current: $93.20
Upside: +5.15%
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $336.18
Upside: +11.25%
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $336.77
Upside: +24.71%
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $97.02
Upside: +28.84%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $81.81
Upside: +23.46%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $21.59
Upside: +1.90%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $87.14
Upside: +28.53%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.68
Upside: +147.02%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $159.36
Upside: +56.88%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $77.32
Upside: -10.76%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $230.84
Upside: -44.98%